Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Maria Diaz"'
Autor:
Maria, Diaz, David, Schiff
Publikováno v:
Current Opinion in Oncology. 34:698-704
Venous thromboembolism (VTE) and other vascular events are common in patients with brain tumors, but their optimal management is not firmly established, in large part due to the competing risk of intracranial hemorrhage (ICH) in this population.There
Autor:
Jasmin Jo, Maria Diaz, Craig Horbinski, Nigel Mackman, Stephen Bagley, Marika Broekman, Janusz Rak, James Perry, Ingrid Pabinger, Nigel S Key, David Schiff
Publikováno v:
Neuro-Oncology.
Patients with diffuse glioma are at high risk of developing venous thromboembolism (VTE) over the course of the disease, with up to 30% incidence in patients with glioblastoma (GBM) and a lower but nonnegligible risk in lower-grade gliomas. Recent an
Autor:
Maria Diaz, Priya Singh, Ivan S. Kotchetkov, Anna Skakodub, Alicia Meng, Christel Tamer, Robert J. Young, Anne S. Reiner, Katherine S. Panageas, Lakshmi V. Ramanathan, Elena Pentsova
Publikováno v:
J Neurooncol
PURPOSE: Circulating tumor cells (CTC) in cerebrospinal fluid (CSF) are a quantitative diagnostic tool for leptomeningeal metastases (LM) from solid tumors, but their prognostic significance is unclear. Our objective was to evaluate CSF-CTC quantific
Autor:
Cliona M. Rooney, Rosa Maria Diaz, Rehan Khan, Stephen J. Russell, Amber Miller, Yumei Zhou, Angela Dispenzieri, Deepak Upreti, Nandakumar Packiriswamy, Kah Whye Peng
Publikováno v:
Leukemia
Oncolytic virus therapy leads to immunogenic death of virus-infected tumor cells and this has been shown in preclinical models to enhance the cytotoxic T-lymphocyte response against tumor-associated antigens (TAAs), leading to killing of uninfected t
Autor:
Eric J. Small, Charles L. Sawyers, David W. Goodrich, Richard M. White, Toby T. Hecht, Timothy C. Thompson, Rosalie C. Sears, John K. Lee, Amina Zoubeidi, William L. Dahut, Massimo Loda, Andrew M. Hruszkewycz, Tamara L. Lotan, Daniel W. Lin, Jeffrey Hildesheim, Mark A. Rubin, Jennifer S. Isaacs, Julia T. Arnold, Maria Diaz Meco, Peter S. Nelson, Charles M. Rudin, Himisha Beltran, David R. Rowley, Adam P. Dicker, Max S. Wicha, James L. Gulley, Howard I. Scher, Abdul Tawab-Amiri, Karen E. Knudsen, Michael M. Shen, Evan Y. Yu, Kathleen Kelly
Publikováno v:
Clin Cancer Res
Lineage plasticity has emerged as an important mechanism of treatment resistance in prostate cancer. Treatment-refractory prostate cancers are increasingly associated with loss of luminal prostate markers, and in many cases induction of developmental
Publikováno v:
Neuro Oncol
INTRODUCTION The 2016 WHO classification describes a subtype of midline gliomas harboring histone 3 (H3) K27M mutations, and the upcoming 2021 edition may include a new subtype of hemispheric diffuse gliomas with H3 G34R/V mutations. Since we began t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ac6bb98e1f1904c1ac353fbac81da7a
https://europepmc.org/articles/PMC8598532/
https://europepmc.org/articles/PMC8598532/
Autor:
Maria Diaz, Anne Reiner, Claudia Huereca, Robert Young, Maria Arcila, Marc Rosenblum, Lakshmi Ramanathan, Tejus Bale, Elena Pentsova
Publikováno v:
Neuro-Oncology. 24:vii4-vii4
BACKGROUND CSF-CTC analysis through the CellSearch® platform has been studied as a diagnostic and prognostic tool for LM from solid tumors. CSF-ctDNA can be detected in LM and/or BM, with unclear significance. We aimed to evaluate CSF-CTCs and CSF-c
Publikováno v:
Biodrugs
New immuno-oncology therapies are improving cancer treatments beyond the former standard of care, as evidenced by the recent and continuing clinical approvals for immunotherapies in a broad range of indications. However, a majority of patients (parti
Autor:
Katherine S. Panageas, Anne S. Reiner, Elena Pentsova, Lakshmi V. Ramanathan, Priya Singh, Maria Diaz, Anna Skakodub, Ivan S. Kotchetkov
Publikováno v:
Neuro Oncol
BACKGROUND CSF-CTC testing using the CellSearch® platform is a validated diagnostic tool for leptomeningeal metastases (LM) from solid tumors. CSF-CTCs can also be detected in patients with brain metastases (BM), but their significance is unclear. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::419fe91be9d74aea32d9b65b27633c55
https://europepmc.org/articles/PMC7650326/
https://europepmc.org/articles/PMC7650326/
Autor:
Lukkana Suksanpaisan, David K. Clarke, John H. Eldridge, Kah Whye Peng, Ayuko Ota-Setlik, Stephen J. Russell, Hinna Akhtar, Carolyn Bomidi, Rianna Vandergaast, Stefan Hamm, Rong Xu, Mulu Z. Tesfay, Amara Luckay, Rosa Maria Diaz, Rebecca M. Nowak, Michael B. Steele, Nathan Jenks
Publikováno v:
Molecular Therapy Oncolytics
Molecular Therapy: Oncolytics, Vol 10, Iss, Pp 1-13 (2018)
Molecular Therapy: Oncolytics, Vol 10, Iss, Pp 1-13 (2018)
Immunotherapy for HPVPOS malignancies is attractive because well-defined, viral, non-self tumor antigens exist as targets. Several approaches to vaccinate therapeutically against HPV E6 and E7 antigens have been adopted, including viral platforms suc